NRBO (NeuroBo Pharmaceuticals) Earnings per share growth in current year

NRBO (NeuroBo Pharma) - company brandmark

NeuroBo Pharmaceuticals develops its drugs within a protected US legal framework, eliminating geopolitical risks. Biomaterial delivery relies on strict temperature control, ensuring supply chain reliability. The annual earnings per share volatility metric visualizes the market valuation, where 94.60 determines the current status of the parameter. The biotech firm relies on an academic approach and retains scientists through options tied to the achievement of clinical milestones.

Net earnings per share growth this year: NeuroBo Pharmaceuticals Inc (NRBO) for 07/04/2022 - 12/07/2024

Financial and market metric breakdowns for NeuroBo Pharmaceuticals, Inc. (NRBO)

- stock value and consensus price forecast:
Fundamental valuation:NeuroBo Pharmaceuticals
Product sample of neurobopharma.com

An investment audit of the issuer requires an analysis of profit dynamics to eliminate the risk of overpaying for the asset. This indicator is calculated as the percentage ratio of the current EPS to the figure for the same period last year, measuring the growth rate of real earnings per share. For NeuroBo Pharmaceuticals (NRBO), this calculation confirms the effectiveness of therapeutic molecule development, reflecting the potential for future profits within the history of annual net income per share growth.

Main competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year GRCE|AIFF: Earnings per share trend in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|RVPH: Net earnings per share growth this year|Expected net earnings per share growth this year MetaVia MTVA|neuraxis.com (NRXS) - Earnings per share growth in current year|Helius Medical Technologies Inc. - Earnings per share increase in current year|PASG (Passage Bio, Inc.) - Earnings growth in current year|bionomics.com.au - Earnings per share trend in current year|Earnings growth in current year NERV|ATHA (Athira) - Earnings per share increase in current year|Addex Therapeutics - Net earnings per share growth this year|ALZN - Net earnings per share growth this year|Cyclerion Therapeutics, Inc. - Earnings growth in current year|Earnings per share increase in current year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Net earnings per share growth this year|Earnings per share growth this year CRGT|Net earnings per share growth this year ATXI|Net earnings per share growth this year Brainstorm Cell (BCLI)|Net earnings per share growth this year CARA (Cara Therapeutics, Inc.)|Net earnings per share growth this year Chromocell Therapeutics Corp CHRO|Earnings growth in current year ELYM (Eliem Therapeutics, Inc.)|Earnings growth in current year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth in current year|Expected net earnings per share growth this year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth in current year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE